Skip to content

13F-HR filed by ABG-WTT Global Life Science Capital Partners GP Ltd

ABG-WTT Global Life Science Capital Partners GP Ltd filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 3 holding rows worth $6,186,632.

Accession
0000950123-23-002333
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 3 entries on the cover page, a total value of $6,186,632 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,186,632 with VALUE read as dollars as filed, 13F file number 028-20836. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MEDAVAIL HOLDINGS INC58406B103COM15,029,480$4,505,838dollars as filed
RAPID MICRO BIOSYSTEMS INC75340L104CLASS A COM1,038,296$1,173,274dollars as filed
PULMONX CORP745848101COM60,204$507,520dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-002333this filing2023-02-14acceptance time not in the bulk data set